Medical genetics
Medicine focused on hereditary disorders
Follow Medical genetics on Notably News to receive short updates to your email — rarely!
We include updates on Consanguinity, Gene therapy, Heritability of IQ, Metabolic disorder, Savior sibling, Genetic testing, Whole genome sequencing, Consanguine marriage, Genetic counseling, Heritability of autism, Paternal age effect, Penetrance, Preimplantation genetic diagnosis, Genetic Information Nondiscrimination Act, Alex Blackwell, Dysmorphic feature ... and more.
March 2025 |
Gene therapy of the human retina
Revakinagene taroretcel received FDA approval in the United States for treating macular telangiectasia type 2, marking a significant advancement in gene therapy for retinal conditions.
|
2024 |
Heritability of autism
Martini et al. twin study suggested that genetic factors have a greater influence on the stability of autistic traits compared to environmental factors.
|
2024 |
Preimplantation genetic diagnosis
Alabama Supreme Court ruled that frozen embryos in test tubes should be considered children, creating significant legal implications for reproductive care and potentially impacting preimplantation genetic diagnosis practices.
|
June 24 2024 |
Grail
Grail was spun out from Illumina as an independent company, ending its previous status as a subsidiary.
|
May 2024 |
Grail
Illumina publicly filed a Form 10 registration statement with the U.S. SEC for a potential capital markets separation of Grail.
|
April 2024 |
Grail
The European Commission approved Illumina's divestment plan for Grail, allowing exploration of a trade sale or capital markets transaction.
|
2023 |
Metabolic disorder
A meta-analysis of six cohort studies involving 484,994 participants was conducted, examining the relationship between metabolic syndrome and Alzheimer's disease risk, finding no significant overall association but identifying links between individual metabolic components and increased AD risk.
|
2023 |
Metabolic disorder
A systematic review and meta-analysis demonstrated the effectiveness of medical nutrition therapy (MNT) in managing metabolic disorders, showing significant improvements in glycemic control, anthropometric measures, lipid profiles, and blood pressure for adults with prediabetes when nutrition interventions are personalized.
|
2023 |
Whole genome sequencing
The Lancet published an opinion suggesting that in the UK, upgrading targeted gene panels might be more practical in the short term, while recommending cautious examination of whole genome sequencing for long-term implementation.
|
October 2023 |
Grail
The European Commission ordered Illumina to divest Grail within twelve months.
|
July 2023 |
Grail
Three separate lawsuits were filed against Grail by former female employees, alleging a 'frat house' and sexually hostile work environment.
|
June 2023 |
Grail
Grail disclosed that 408 patients were incorrectly informed they may have cancer, attributing the error to a PWNHealth software configuration issue.
|
January 2023 |
Whole genome sequencing
UK Biobank released an additional 300,000 whole genome sequences.
|
2022 |
Heritability of autism
A study conducted on 86 mother-child dyads over 18 months found that prior maternal depression did not predict child behavior problems later.
|
September 2022 |
Grail
An administrative judge ruled against the FTC's antitrust position regarding the Illumina-Grail merger.
|
2021 |
Genetic testing
The UAE Genome Project is set to be fully operational, establishing strategic partnerships with medical research centers and investing in healthcare services to prevent genetic diseases through genetic sciences and sequencing techniques.
|
2021 |
Genetic testing
A study by Khalifa University identifies four genetic markers associated with type 2 diabetes among UAE citizens for the first time, contributing to personalized medical research.
|
2021 |
Whole genome sequencing
Whole genome and exome sequencing were further deliberated as potential newborn screening tools.
|
2021 |
Whole genome sequencing
The NIH funded BabySeq2, an implementation study expanding the original BabySeq project by enrolling 500 infants from diverse families to track the effects of genomic sequencing on pediatric care.
|
November 2021 |
Whole genome sequencing
UK Biobank made available the largest public dataset of whole genomes through a web platform, with 500,000 genomes linked to anonymized medical information.
|
June 2021 |
Grail
Grail launched its Galleri test, a liquid biopsy multi-cancer early detection test, which was promoted as a groundbreaking medical screening tool.
|
March 2021 |
Grail
The Federal Trade Commission (FTC) sued to block Illumina's vertical merger with Grail.
|
2020 |
Genetic testing
The Genographic Project was discontinued after fifteen years of DNA sampling and research, marking the end of the large-scale genetic research initiative.
|
2020 |
GENCODE
Completed the first pass manual annotation of the mouse reference genome, started cooperation with RefSeq and Uniprot for annotation convergence, improved lncRNA annotation, and reviewed and improved annotation for protein-coding genes associated with SARS-CoV-2 infection in response to the COVID-19 pandemic.
|
2020 |
Heritability of autism
A study was published exploring the sex bias mechanism in autism spectrum disorder, focusing on genetic differences between males and females related to X chromosome mutations.
|
December 2020 |
GENCODE
Release of Gencode 36 for human genome annotations, utilizing the latest GRCh38 human reference genome assembly.
|
December 2020 |
GENCODE
Release of Gencode M25 for mouse genome annotations.
|
November 27 2020 |
Grail
Grail announced a commercial partnership with the National Health Service (England) to trial the Galleri test, with reporting expected in 2026.
|
September 2020 |
Grail
Illumina announced an agreement to purchase Grail for $7.1 billion.
|
June 2020 |
100,000 Genomes Project
Lifebit, a UK-based biotechnology company, was selected to provide the trusted research environment linking genomic data with academic research institutions.
|
April 2020 |
The Resilience Project
The Resilience Project initiated a participatory research study focused on individuals in the United States, aimed at investigating severe genetic disorders.
|
July 2019 |
100,000 Genomes Project
Genomics England announced Data Release 7, making the 100,000th whole genome available to researchers.
|
July 2019 | Exact Sciences announced the acquisition of Genomic Health to expand their portfolio of medical tests. |
June 2019 |
Whole genome sequencing
Veritas Genetics cut the cost for whole genome sequencing to $599.
|
2018 |
GENCODE
Added a CRISPR/Cas9 track on human and model organism assemblies to assist in searching for appropriate guide sequences with potential binding sites near transcribed regions.
|
2018 |
Heritability of autism
Richter et al. found a strong association between the TAOK2 gene and autism.
|
2018 |
Whole genome sequencing
Researchers at Rady Children's Hospital determined that rapid whole-genome sequencing could diagnose genetic disorders in time to change acute medical management and improve infant outcomes.
|
December 2018 |
100,000 Genomes Project
The project reached its full milestone of 100,000 whole genome sequences.
|
2017 |
Whole genome sequencing
BGI began offering whole genome sequencing for $600.
|
March 2017 |
Whole genome sequencing
Retrospective cohort study of acutely ill inpatient infants concluded at Rady Children's Hospital, demonstrating significant diagnostic and clinical utility of rapid whole-genome sequencing.
|
March 8 2017 |
Genetic Information Nondiscrimination Act
HR 1313 - Preserving Employee Wellness Programs Act was introduced in the 115th Congress by Chairwoman Virginia Foxx, potentially allowing employers to demand workers' genetic test results. The bill was reported out of committee to the full House for debate but did not pass before the congressional term ended.
|
2016 |
100,000 Genomes Project
Welsh government issued a statement of intent, considering participation in the 100,000 Genomes Project.
|
2016 |
Whole genome sequencing
Veritas Genetics began selling whole genome sequencing, including a report, for $999.
|
July 2016 |
Whole genome sequencing
Retrospective cohort study of acutely ill inpatient infants began at Rady Children's Hospital Institute for Genomic Medicine in San Diego, examining rapid whole-genome sequencing (rWGS).
|
2015 |
100,000 Genomes Project
Northern Ireland and Scotland joined the 100,000 Genomes Project, with plans to start work the following year.
|
2015 |
Heritability of autism
Meta-analysis of previous twin studies concluded that genetics contribute between 64% to 91% to the chances of developing autism.
|
2015 |
Whole genome sequencing
The NHGRI estimated the cost of obtaining a whole-genome sequence at around $1,500.
|
2015 |
Grail
Grail was founded as a biotechnology and pharmaceutical startup in San Francisco, with Illumina as its parent company. Richard Klausner, former National Cancer Institute director, advocated for the new business and joined its board of directors.
|
We are only showing the most recent entries for this topic. |
This contents of the box above is based on material from the Wikipedia articles The Resilience Project, Nutritional epigenetics, GENCODE, Grail (company), Preimplantation genetic diagnosis, Whole genome sequencing, Heritability of autism, Gene therapy of the human retina, Genomic Health, Metabolic disorder, Genetic testing, Genetic Information Nondiscrimination Act, Consanguinity & 100,000 Genomes Project, which are released under the Creative Commons Attribution-ShareAlike 4.0 International License.